These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Conversion from cyclosporine to azathioprine after renal transplantation: long-term effects on renal function, rejection, and allograft survival. Maddux MS; Veremis SA; Bauma WD; Pollak R; Mozes MF Transplant Proc; 1988 Jun; 20(3 Suppl 3):152-4. PubMed ID: 3291231 [No Abstract] [Full Text] [Related]
24. The effect of low-dose cyclosporine A and multiple blood transfusions on heart graft survival in highly sensitized rats. de Bruin RW; Bouwman E; Heineman E; Marquet RL; Jeekel J Transplant Proc; 1988 Jun; 20(3 Suppl 3):1094-6. PubMed ID: 3291217 [No Abstract] [Full Text] [Related]
25. Cyclosporine in transplantation of the liver in the dog. Williams JW; Peters TG; Haggitt R; Van Voorst S Surg Gynecol Obstet; 1983 Jun; 156(6):767-73. PubMed ID: 6344281 [TBL] [Abstract][Full Text] [Related]
26. Influence of early cyclosporine dosage and plasma and whole blood levels on acute rejections in cadaveric renal allograft recipients. Lindholm A; Lundgren G; Fehrman I; Weibull H; Brynger H; Frödin L; Flatmark A Transplant Proc; 1988 Jun; 20(3):444-6. PubMed ID: 3289181 [No Abstract] [Full Text] [Related]
27. Prolongation of rat skin and cardiac allograft survival by low molecular weight heparin. Shapira OM; Rene H; Lider O; Pfeffermann RA; Shemin RJ; Cohen IR J Surg Res; 1999 Jul; 85(1):83-7. PubMed ID: 10383842 [TBL] [Abstract][Full Text] [Related]
29. A study of eleven drug regimens using cyclosporin-A to suppress renal allograft rejection in the dog. Homan WP; French ME; Millard PR; Morris PJ Transplant Proc; 1981 Mar; 13(1 Pt 1):397-401. PubMed ID: 7022860 [No Abstract] [Full Text] [Related]
31. The use of low-dose cyclosporine A in combination with azathioprine and steroids in renal transplantation. Slapak M; Geoghegan T; Digard N; Ahmed K; Sharman VL; Crockett R Transplant Proc; 1987 Apr; 19(2 Suppl 2):41-5. PubMed ID: 3551255 [No Abstract] [Full Text] [Related]
33. Acute skin graft rejection can be prevented and treated in rat models by malononitrilamides. Schorlemmer HU; Schwab W; Ruuth E; Kurrle R Transplant Proc; 1996 Dec; 28(6):3048-50. PubMed ID: 8962182 [No Abstract] [Full Text] [Related]
34. Cyclosporine dosage can be reduced when used in combination with an anti-intercellular adhesion molecule-1 monoclonal antibody in rats undergoing heterotopic heart transplantation. Harrison PC; Mainolfi E; Madwed JB J Heart Lung Transplant; 1998 Feb; 17(2):150-7. PubMed ID: 9513853 [TBL] [Abstract][Full Text] [Related]
35. Prolongation of skin allograft survival in mice following administration of ALLOTRAP. Buelow R; Veyron P; Clayberger C; Pouletty P; Touraine JL Transplantation; 1995 Feb; 59(4):455-60. PubMed ID: 7878745 [TBL] [Abstract][Full Text] [Related]
37. [Contrary action of khingamin on the rejection of a skin allograft and on the level of antibody-producing cells in mice]. Gamburg LIu; Cheredeev AN Biull Eksp Biol Med; 1987 Jun; 103(6):727-30. PubMed ID: 3297194 [TBL] [Abstract][Full Text] [Related]
38. Cyclosporine in pediatric liver transplantation: is there a therapeutic blood level that abrogates rejection? Margarit C; Martinez Ibáñez V; Potau N; Iglesias J; Boix Ochoa J Transplant Proc; 1988 Jun; 20(3 Suppl 3):369-74. PubMed ID: 3291270 [No Abstract] [Full Text] [Related]
39. Role of cyclosporine A in the treatment of acute renal allograft rejection. Gascon M; Donnelly S; Lowry RP Transplant Proc; 1987 Aug; 19(4):3481-5. PubMed ID: 3303519 [No Abstract] [Full Text] [Related]
40. Synergistic activity of malononitrilamides with cyclosporine to control and reverse xenograft rejection. Schorlemmer HU; Kurrle R Int J Tissue React; 1997; 19(3-4):149-56. PubMed ID: 9506316 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]